Trial NCT05848843

View at ClinicalTrials.gov 
Org. Study IDs: 2022-0782
Secondary IDs: NCI-2023-03640

Last trial update was posted on 2024-01-23

MeSH Interventions

Adagrasib Durvalumab

MeSH Conditions

Gastrointestinal Neoplasms Intestinal Neoplasms Lung Neoplasms

Other Conditions

Gastro-intestinal Cancer Lung Cancer

Stopping Reasons

0 participant accrual

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID